<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03163212</url>
  </required_header>
  <id_info>
    <org_study_id>19804</org_study_id>
    <nct_id>NCT03163212</nct_id>
  </id_info>
  <brief_title>Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants</brief_title>
  <official_title>Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Gerber Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the safety and tolerability of supplementation with bovine
      lactoferrin with fructo-oligosaccharide a simple sugar in very low birth weight infants.
      Lactoferrin is a major whey protein in mother's milk and plays a role in promoting a mature
      and healthy gut. It also has antimicrobial and immunomodulation activities.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim 1: To evaluate the safety and tolerability of three different lactoferrin/FOS doses in
      preterm infants

        1. Lactoferrin/FOS related adverse events and serious adverse events

        2. Time reaching full feeds while receiving lactoferrin/FOS (120 ml/kg/day)

        3. Episodes of not receiving enteral feedings for &gt; 24 hours once feeding is initiated

      Aim 2: To evaluate lactoferrin/FOS absorption and excretion

        1. Examine lactoferrin/FOS levels in saliva, urine, plasma, and stool

        2. Examine lactoferrin levels in materal and human donor milk

      Aim 3: To evaluate the effect of lactoferrin/FOS on the intestinal microbiome structure
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2017</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Dose escalation design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Definitely related study solution serious adverse event</measure>
    <time_frame>30 days while receiving study solution</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Day after birth to reach 120ml/kg of enteral feeds</measure>
    <time_frame>30 days while receiving study solution</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days not receiving any feedings after lactoferrin/FOS administration</measure>
    <time_frame>30 days while receiving study solution</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Safety Issues</condition>
  <condition>Tolerance</condition>
  <condition>Very Low Birth Weight Infant</condition>
  <arm_group>
    <arm_group_label>Lactoferrin/FOS 100mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 mg/kg enteral administration daily for 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactoferrin/FOS 200mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 mg/kg enteral administration daily for 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactoferrin/FOS 300mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>300 mg/kg enteral administration daily for 30 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactoferrin/FOS</intervention_name>
    <description>Bovine Lactoferrin/FOS 100mg/ml dissolved in sterile water</description>
    <arm_group_label>Lactoferrin/FOS 100mg/kg</arm_group_label>
    <arm_group_label>Lactoferrin/FOS 200mg/kg</arm_group_label>
    <arm_group_label>Lactoferrin/FOS 300mg/kg</arm_group_label>
    <other_name>BF100</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt; 15 days of age and receiving enteral feedings

          -  &lt; 1500 grams birth weight

          -  &lt; 37 weeks gestation

        Exclusion Criteria:

          -  Congenital bowel obstruction (esophageal, duodenal, small bowel or anal atresias,
             Hirschsprung disease, malrotation)

          -  Known necrotizing enterocolitis or bowel perforation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David A Kaufman, MD</last_name>
    <phone>434-924-5428</phone>
    <email>dak4r@virginia.edu</email>
  </overall_contact>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2017</study_first_submitted>
  <study_first_submitted_qc>May 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>May 19, 2017</last_update_submitted>
  <last_update_submitted_qc>May 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>David A Kaufman</investigator_full_name>
    <investigator_title>Neonatologist</investigator_title>
  </responsible_party>
  <keyword>Lactoferrin/FOS Supplementation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Specimens which have been unidentified may be shared with outside labs for analysis</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

